ArticleOPEN ACCESS

Bevacizumab (avastin)

American Journal of Neuroradiology
DOI: 10.3174/ajnr.A1987
101Citations
Citations of this article
212Readers
Mendeley users who have this article in their library.

Abstract

Bevacizumab is a humanized monoclonal antibody that was the first FDA approved therapy designed to inhibit angiogenesis. This paper will review the mechanism of action and clinical role of this antiangiogenic agent.

Cite

CITATION STYLE

APA

Mukherji, S. K. (2010, February). Bevacizumab (avastin). American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.A1987

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free